Article
Paris - Androgenetic alopecia researchers have recently made important discoveries regarding pathogenic pathways for the hair-loss disorder and possible new approaches to treatment, Antonella Tosti, M.D., said at the World Congress of Dermatology.
Journey Medical Launches Emrosi, a Dual-Release Minocycline for Rosacea
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Top 5 Articles of the Week: March 16-21
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
The Weekly Roundup: March 17-21
The Rx Recap: March 16-22